John Paul Waymack
Chief Tech/Sci/R&D Officer at MOLECULIN BIOTECH, INC.
John Paul Waymack active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MOLECULIN BIOTECH, INC. | Chief Tech/Sci/R&D Officer | - | - |
Pam-Bio Ltd.
 Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Director/Board Member | - | - |
Career history of John Paul Waymack
Former positions of John Paul Waymack
| Companies | Position | Start | End |
|---|---|---|---|
| PURPLE BIOTECH LTD | Chairman | 1968-08-11 | 2019-06-30 |
| Chief Tech/Sci/R&D Officer | 1968-08-11 | 2020-01-08 | |
| Founder | 1968-08-11 | 2020-01-08 | |
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | - | - |
| The United States Army Medical Service Corps | Corporate Officer/Principal | - | - |
Kitov Pharmaceuticals Ltd.
 Kitov Pharmaceuticals Ltd. Medical DistributorsDistribution Services Part of Purple Biotech Ltd., Kitov Pharmaceuticals Ltd. is committed to providing cancer patients with first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance. The Israeli company's proposed drug, CM24, attenuates/block tumor growth and metastatic processes, while their novel small molecule, NT219, targets both IRS1/2 and STAT3. CM24 is a monoclonal antibody blocking CEACAM1, and NT219 targets the novel cancer drug resistance pathways. Kitov Pharmaceuticals was acquired by Mainrom Line Logistics Ltd. on July 18, 2013. | Chairman | - | - |
| Chief Tech/Sci/R&D Officer | - | - | |
| The University of Texas at Austin | Corporate Officer/Principal | - | - |
Statistics
International
| United States | 5 |
| Israel | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Chairman | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PURPLE BIOTECH LTD | Health Technology |
| MOLECULIN BIOTECH, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Pam-Bio Ltd.
Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Health Technology |
Kitov Pharmaceuticals Ltd.
Kitov Pharmaceuticals Ltd. Medical DistributorsDistribution Services Part of Purple Biotech Ltd., Kitov Pharmaceuticals Ltd. is committed to providing cancer patients with first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance. The Israeli company's proposed drug, CM24, attenuates/block tumor growth and metastatic processes, while their novel small molecule, NT219, targets both IRS1/2 and STAT3. CM24 is a monoclonal antibody blocking CEACAM1, and NT219 targets the novel cancer drug resistance pathways. Kitov Pharmaceuticals was acquired by Mainrom Line Logistics Ltd. on July 18, 2013. | Distribution Services |
| The United States Army Medical Service Corps |
- Stock Market
- Insiders
- John Paul Waymack
- Experience
